Oral Controlled Release at Bend Research

Pharmaceutical firms often desire to delivery crystalline and solubilized forms of compounds in once- or twice-daily dosing regimes to maximize therapeutic effect and patient compliance. To meet this need, Bend Research has developed osmotic tablet technologies that release soluable and insoluable drugs in a predictable, reliable and stable manner. Bend Research also has experience with, and welcomes, projects that require customized, nonconventional "optimized for pharmacology" release profiles.

Topics: 
Modified & Targeted Release